SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001741830-23-000029
Filing Date
2023-05-10
Accepted
2023-05-10 16:08:32
Documents
14
Period of Report
2023-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kron-20230510.htm   iXBRL 8-K 36471
2 EX-99.1 kronq123ex-991.htm EX-99.1 48312
6 image_0.jpg GRAPHIC 30771
  Complete submission text file 0001741830-23-000029.txt   275144

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kron-20230510.xsd EX-101.SCH 1918
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kron-20230510_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kron-20230510_pre.xml EX-101.PRE 13060
8 EXTRACTED XBRL INSTANCE DOCUMENT kron-20230510_htm.xml XML 11810
Mailing Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402 (650) 781-5200
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39592 | Film No.: 23906395
SIC: 2834 Pharmaceutical Preparations